虽然哮喘死亡率急剧下降,直到2000年代中期,在过去的十年中,不同国家的死亡率停滞不前。
本研究的目的是描述法国因哮喘死亡的患者的医疗资源消耗。
本研究使用法国国家健康数据系统的数据进行。在2013年至2017年期间死于哮喘的患者通过ICD10代码J45和J46进行鉴定。收集了医疗保健消费数据。根据年龄将患者分为四类:75,(18-75),(12-18),(0-12)。根据GINA指南对ICS的每日剂量进行分类。
共纳入3829例患者。在43.8%中未观察到ICS或不足的ICS剂量,50.6%,48.1%,54.0%的患者年龄75岁,(18-74),(12-18),和(0-12)年,分别。在37.2%中观察到六个或更多个SABA罐的分配,49.0%,70.3%的患者年龄在75岁,(18-75),和(12-18)年,分别。奥马珠单抗分配率非常低[年龄75和(18-75)岁的患者分别为1.1%和2.8%]。肺科医生就诊的患者比例为13.8%和14.6%,患者为75和(18-75)年,分别。肺功能检查仅占18.6%,28.3%,和25.9%的患者75,(18-75)和(12-18)年,分别。
一半死于哮喘的患者接受了不足的ICS剂量,只有一小部分能够获得生物治疗。不到15%的人被转诊给专家。
Although asthma mortality declined sharply until the mid-2000s, a stagnation in mortality has been observed over the past decade in different countries.
The objective of this study is to describe healthcare resource consumption for patients who died from asthma in France.
This study was conducted using data from the French National Health Data System. Patients who died from asthma between 2013 and 2017 were identified by the ICD10 codes J45 and J46. Health care consumption data were collected. Patients were categorized into four categories according to age: ⩾75, (18-75), (12-18), (0-12). Daily doses of ICS were categorized according to GINA guidelines.
A total of 3829 patients were included. No ICS or an inadequate ICS dose was observed in 43.8%, 50.6%, 48.1%, and 54.0% of patients aged ⩾75, (18-74), (12-18), and (0-12) years, respectively. Dispensation of six or more SABA canisters was observed in 37.2%, 49.0%, and 70.3% of patients aged of ⩾75, (18-75), and (12-18) years, respectively. Omalizumab dispensation rate was very low [1.1% and 2.8% in patients aged ⩾75 and (18-75) years)]. The proportion of patients with a pulmonologist office visit was 13.8% and 14.6% in patients ⩾75 and (18-75) years, respectively. A lung function test was noted in only 18.6%, 28.3%, and 25.9% of patients ⩾75, (18-75) and (12-18) years, respectively.
Half of the patients who died from asthma received inadequate ICS doses and only a small proportion had access to biological therapies. Less than 15% were referred to a specialist.